Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Pharmacokinetic Study of Omecamtiv Mecarbil in Heart Failure Patients

This study has been withdrawn prior to enrollment.
(Study cancelled due to sponsor's decision to redesign the study)
Sponsor:
Information provided by:
Amgen
ClinicalTrials.gov Identifier:
NCT01077167
First received: February 25, 2010
Last updated: May 26, 2011
Last verified: May 2011
No Study Results Posted on ClinicalTrials.gov for this Study
Study was withdrawn before participants were enrolled.
  Study Status: This study has been withdrawn prior to enrollment.
  Estimated Study Completion Date: May 2011
  Primary Completion Date: May 2011 (Final data collection date for primary outcome measure)